Wanjia Group Holdings Full Year 2024 Earnings: HK$0.071 loss per share (vs HK$0.003 profit in FY 2023)

Wanjia Group Holdings (HKG:401) Full Year 2024 Results

Key Financial Results

• Revenue: HK$181.1m (up 4.3% from FY 2023).
• Net loss: HK$40.0m (down from HK$1.82m profit in FY 2023).
• HK$0.071 loss per share (down from HK$0.003 profit in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

The primary driver behind last 12 months revenue was the Hemodialysis Treatment and Consultancy Service Business segment contributing a total revenue of HK$129.6m (72% of total revenue). Notably, cost of sales worth HK$126.4m amounted to 70% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to HK$35.8m (38% of total expenses). Explore how 401's revenue and expenses shape its earnings.

Wanjia Group Holdings' share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that Wanjia Group Holdings is showing 2 warning signs in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com